Received for publication August 18, 2004.
Revised December 21, 2004.
Accepted for publication December 29, 2004.

-arrestin 2 Dependent AT_1A Receptor Mediated Pathway of Chemotaxis

Abstract

Chemotaxis is a cellular response that directs cell migration toward a chemical gradient and is fundamental to a variety of cellular processes. The receptors for most known chemokines belong to the seven transmembrane spanning superfamily and signal through members of the G_i family. -arrestins, in addition to regulating desensitization, have emerged as potential mediators of G-protein independent signaling pathways and have been implicated in several chemotactic pathways. Here we report a system wherein chemotaxis is stimulated in a - arrestin 2-dependent and apparently G-protein- independent manner. HEK293 cells with stable expression of the angiotensin II receptor type 1A (AT_1AR) undergo chemotaxis in response to Ang II. An Ang II peptide analogue S¹I⁴I⁸ Ang II that is unable to activate G- protein mediated responses induces chemotaxis in these cells that is unaffected by pertussis toxin-mediated suppression of G_i. Suppression of -arrestin 2 expression using siRNA essentially eliminated AT_1AR mediated chemotaxis induced by either Ang II or the S¹I⁴I⁸ Ang II peptide, while having no effect on EGF induced chemotaxis. It also abolished chemotaxis induced by LPA, which was completely sensitive to pertussis toxin. In contrast, reduction of G_q/11 through siRNA and inhibition of PKC, ERK1/2, or PI-3- Kinase did not diminish AT_1AR mediated chemotaxis. Inhibiting p38 MAPK decreased AT_1AR mediated chemotaxis and eliminated EGF mediated chemotaxis, suggesting that p38 plays a role in chemotaxis that is not specific to the AT_1AR in this system. These data suggest that - arrestin 2 can mediate chemotaxis through mechanisms which may be G-protein independent (Ang II receptors) or dependent (LPA receptors).

Key words: Chemotactic peptides, Angiotensin, NGF/EGF, Gi family, Gq/11 family, GRKs, barrestins

This article has been cited by other articles:

				C. D. Nelson, J. J. Kovacs, K. N. Nobles, E. J. Whalen, and R. J. Lefkowitz {beta}-Arrestin Scaffolding of Phosphatidylinositol 4-Phosphate 5-Kinase I{alpha} Promotes Agonist-stimulated Sequestration of the {beta}2-Adrenergic Receptor J. Biol. Chem., July 25, 2008; 283(30): 21093 - 21101. [Abstract] [Full Text] [PDF]

				B. Lagane, K. Y. C. Chow, K. Balabanian, A. Levoye, J. Harriague, T. Planchenault, F. Baleux, N. Gunera-Saad, F. Arenzana-Seisdedos, and F. Bachelerie CXCR4 dimerization and {beta}-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome Blood, July 1, 2008; 112(1): 34 - 44. [Abstract] [Full Text] [PDF]

				M. Zoudilova, P. Kumar, L. Ge, P. Wang, G. M. Bokoch, and K. A. DeFea beta-Arrestin-dependent Regulation of the Cofilin Pathway Downstream of Protease-activated Receptor-2 J. Biol. Chem., July 13, 2007; 282(28): 20634 - 20646. [Abstract] [Full Text] [PDF]

				P. Kumar, C. S. Lau, M. Mathur, P. Wang, and K. A. DeFea Differential effects of beta-arrestins on the internalization, desensitization and ERK1/2 activation downstream of protease activated receptor-2 Am J Physiol Cell Physiol, July 1, 2007; 293(1): C346 - C357. [Abstract] [Full Text] [PDF]

				N. Parameswaran, C. S. Pao, K. S. Leonhard, D. S. Kang, M. Kratz, S. C. Ley, and J. L. Benovic Arrestin-2 and G Protein-coupled Receptor Kinase 5 Interact with NF{kappa}B1 p105 and Negatively Regulate Lipopolysaccharide-stimulated ERK1/2 Activation in Macrophages J. Biol. Chem., November 10, 2006; 281(45): 34159 - 34170. [Abstract] [Full Text] [PDF]

				D. Roosterman, T. Goerge, S. W. Schneider, N. W. Bunnett, and M. Steinhoff Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev, October 1, 2006; 86(4): 1309 - 1379. [Abstract] [Full Text] [PDF]

				N. J. Smith and L. M. Luttrell Signal Switching, Crosstalk, and Arrestin Scaffolds: Novel G Protein-Coupled Receptor Signaling in Cardiovascular Disease Hypertension, August 1, 2006; 48(2): 173 - 179. [Full Text] [PDF]

				M. R. Bruchas, T. A. Macey, J. D. Lowe, and C. Chavkin Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes J. Biol. Chem., June 30, 2006; 281(26): 18081 - 18089. [Abstract] [Full Text] [PDF]

				M. G. H. Scott, V. Pierotti, H. Storez, E. Lindberg, A. Thuret, O. Muntaner, C. Labbe-Jullie, J. A. Pitcher, and S. Marullo Cooperative Regulation of Extracellular Signal-Regulated Kinase Activation and Cell Shape Change by Filamin A and {beta}-Arrestins. Mol. Cell. Biol., May 1, 2006; 26(9): 3432 - 3445. [Abstract] [Full Text] [PDF]

				L. Hunyady and K. J. Catt Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II Mol. Endocrinol., May 1, 2006; 20(5): 953 - 970. [Abstract] [Full Text] [PDF]

				J. Tfelt-Hansen, J. L. Hansen, S. Smajilovic, E. F. Terwilliger, S. Haunso, and S. P. Sheikh Calcium receptor is functionally expressed in rat neonatal ventricular cardiomyocytes Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1165 - H1171. [Abstract] [Full Text] [PDF]

				P. J. Atkinson, K. W. Young, S. J. Ennion, J. N. C. Kew, S. R. Nahorski, and R. A. J. Challiss Altered Expression of Gq/11{alpha} Protein Shapes mGlu1 and mGlu5 Receptor-Mediated Single Cell Inositol 1,4,5-Trisphosphate and Ca2+ Signaling Mol. Pharmacol., January 1, 2006; 69(1): 174 - 184. [Abstract] [Full Text] [PDF]

				S. K. Shenoy and R. J. Lefkowitz Seven-Transmembrane Receptor Signaling Through {beta}-Arrestin Sci. Signal., November 1, 2005; 2005(308): cm10 - cm10. [Abstract] [Full Text] [PDF]